Congress maintains existing FDA funding levels temporarily
This article was originally published in The Rose Sheet
Executive Summary
Unable to work out a deal to pass appropriations measures by the end of the fiscal year, Congress passes a continuing resolution Sept. 30, maintaining funding for FDA and other federal agencies at fiscal 2010 levels. Resolution expires Dec. 3. If Republicans win a majority in the midterm elections, they may force passage of another continuing resolution that would allow them to set spending levels in 2011 after new members take their seats. In regular appropriations legislation, the Senate Appropriations subcommittee with FDA oversight appropriated $261.5 mil. for the Center for Food Safety and Applied Nutrition and $357 mil. for the Center for Drug Evaluation and Research, both increases over last fiscal year. The House has not yet marked up its version of the agriculture appropriations bill, so funding for individual FDA centers was not known (1"The Rose Sheet" Aug. 2, 2010)
You may also be interested in...
FDA Funding Stalls As Chances Grow For Omnibus Or Continuing Resolution
The House Appropriations Committee postponed a markup of fiscal 2011 agriculture funding legislation July 27, leaving FDA's fiscal 2011 funding in limbo
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.